Author(s):
S. Jenifer Ashwini, S. T. Narenderan, S. N. Meyyanathan, B. Babu, B. Gowramma
Email(s):
snmeyyanathan@jssuni.edu.in
DOI:
10.5958/0974-360X.2019.00384.6 
Address:
S. Jenifer Ashwini1, S. T. Narenderan1, S. N. Meyyanathan1*, B. Babu1, B. Gowramma2
1Department of Pharmaceutical Analysis, JSS College of Pharmacy (JSS Academy of Higher Education and Research, Mysuru) Udhagamandalam, Tamil Nadu, India.
2Department of Pharmaceutical Chemistry, JSS College of Pharmacy (JSS Academy of Higher Education and Research, Mysuru) Udhagamandalam, Tamil Nadu, India.
*Corresponding Author
Published In:
Volume - 12,
Issue - 5,
Year - 2019
ABSTRACT:
A validated direct chiral HPLC method was developed for the separation of enantiomers of Mefloquine. The separation was achieved using chiral PAK IG-3 (250 x 4.6 mm) 3µm column. The mobile phase was composed of 10 mM ammonium acetate and methanol in the ratio of 30:70, v/v. The flow rate of the mobile phase was set at 0.7 ml/min. The detection wavelength was set at 284 nm with column temperature maintained at 25°C. The retention time of both (+) and (-) enantiomers was found to be 4.59 min and 6.47 min, respectively under a runtime of 10 min. The method was validated as per ICH guidelines. The method was found to be linear over a concentration range of 20 – 120 µg/ml and 15 – 105 µg/ml for (+) and (-) Mefloquine enantiomers, respectively. The chiral assay of Mefloquine in a pharmaceutical formulation was performed and the recoveries ranged from 99.3 to 99.9 %. The detection limit for the (+) and (-) enantiomers was found to be 5.5 µg/ml and 5µg/ml, respectively.
Cite this article:
S. Jenifer Ashwini, S. T. Narenderan, S. N. Meyyanathan, B. Babu, B. Gowramma. A Validated Chiral HPLC Method for the Enantiomeric separation of Mefloquine. Research J. Pharm. and Tech. 2019; 12(5):2304-2308. doi: 10.5958/0974-360X.2019.00384.6
Cite(Electronic):
S. Jenifer Ashwini, S. T. Narenderan, S. N. Meyyanathan, B. Babu, B. Gowramma. A Validated Chiral HPLC Method for the Enantiomeric separation of Mefloquine. Research J. Pharm. and Tech. 2019; 12(5):2304-2308. doi: 10.5958/0974-360X.2019.00384.6 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2019-12-5-43